STAT+: Generics companies fought to stop the new drug pricing law. But they may end up benefiting
STAT
FEBRUARY 10, 2023
WASHINGTON — Generic drugmakers lobbied hard against Democrats’ new law empowering Medicare to negotiate prescription drug prices. Giving the government such power seemed like an admission that generic medicines don’t do enough to keep costs down.
228 
Let's personalize your content